CLINICAL_TRIALS
trial_result
· 2025-04-20
Clinical Trial Update: Intraperitoneal Bupivacaine for Pelvic Organ Prolapse [Phase 4]
Summary
Phase 4 clinical trial evaluating intraperitoneal bupivacaine for pelvic organ prolapse has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Pelvic Organ Prolapse | Phase 4 | Status: COMPLETED | Results posted: 2025-04-20